CANCON-2018 saw deliberations on establishing consensus guidelines for improving outcomes in head & neck cancer.
A successful treatment depends on the intricate understanding of all the variables at play and
Cytecare gets fund infusion of $31 million from Goldman Sach
Goldman invests $30 Million in Cytecare Hospitals
Cytecare raises $30 million from Goldman Sachs and other investors
Cytecare Hospital raises $31 Million from Goldman Sachs, HNIs